샘플 요청 목록

 카트 문의
시장보고서
상품코드
1737418

세계의 SaMD(Software as a Medical Device) 시장

Software as a Medical Device
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 379 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

SaMD(Software as a Medical Device) 세계 시장은 2030년까지 5,370만 달러에 달할 전망

2024년에 2,220만 달러로 추정되는 SaMD(Software as a Medical Device) 세계 시장은 2024년부터 2030년까지 CAGR 15.9%로 성장하여 2030년에는 5,370만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 클라우드 전개는 CAGR 14.1%를 기록하며 분석 기간 종료시에는 3,200만 달러에 달할 것으로 예측됩니다. 온프레미스 전개 부문의 성장률은 분석 기간 동안 CAGR 18.8%로 추정됩니다.

미국 시장은 600만 달러로 추정, 중국은 CAGR 20.7%로 성장 예측

미국의 SaMD(Software as a Medical Device) 시장은 2024년에 600만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 20.7%로 2030년까지 1,160만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 11.9%와 14.1%로 예측됩니다. 유럽에서는 독일이 CAGR 약 12.6%로 성장할 것으로 예측됩니다.

세계의 SaMD(Software as a Medical Device) 시장 - 주요 동향과 촉진요인 정리

코드만으로 치료할 수 있을까? 소프트웨어가 SaMD(Software as a Medical Device)가 헬스케어의 상식을 바꾸는 이유

SaMD(Software as a Medical Device)는 하드웨어에 의존하지 않는 소프트웨어 프로그램이 진단, 치료 추천, 질병 모니터링 등의 기능을 수행할 수 있도록함으로써 헬스케어에 혁명을 일으키고 있습니다. 기기에 내장된 기존 소프트웨어와 달리 SaMD는 모바일 기기, 클라우드 플랫폼 또는 데스크톱 애플리케이션에서 자율적으로 작동하여 원격 환자 관리 및 데이터 기반 임상적 의사결정을 가능하게 합니다. 스마트폰의 ECG 알고리즘을 통한 부정맥 감지부터 당뇨병 예측 소프트웨어를 통한 인슐린 투여 최적화까지, SaMD는 특히 만성질환 관리, 정신건강, 방사선 의학, 디지털 치료학 분야에서 의료 서비스 제공 방식을 변화시키고 있습니다.

SaMD가 특히 파괴적인 이유는 물리적 제조 없이도 임상 기능을 대규모로 제공할 수 있다는 점입니다. 이러한 민첩성은 신속한 업데이트, 반복적인 개선, 실시간 데이터 분석을 가능하게 하며, 이는 종양학, 신경학, 희귀질환과 같은 복잡한 질병을 관리하는 데 필수적인 요소입니다. 또한, COVID-19 사태는 원격 진단 및 디지털 분류를 위한 SaMD 도구의 검증을 가속화하여 FDA 및 EMA와 같은 규제 기관이 승인을 위한 패스트 트랙 경로를 구축할 수 있는 길을 열어주었습니다. 개인화된 비침습적, 비침습적, 지속적인 모니터링 솔루션에 대한 수요는 그 어느 때보다 높으며, SaMD는 진화하는 치료의 핵심으로 자리매김하고 있습니다.

제약사부터 지불자까지 이해관계자들이 SaMD에 결집하는 이유는 무엇일까?

클라우드 컴퓨팅, 인공지능, 모바일 기술의 융합은 임상과 소비자 모두에서 SaMD를 활용할 수 있는 비옥한 환경을 조성하고 있습니다. 제약사들은 디지털 바이오마커와 실제 데이터를 활용해 치료 효과를 높이고 환자의 복약 순응도를 모니터링함으로써 SaMD를 의약품 개발 및 시판 후 조사 전략에 통합하려는 움직임이 가속화되고 있습니다. 또한, 이러한 소프트웨어 솔루션은 동반진단, 커넥티드 약물전달 기기, 웨어러블 센서와 결합하여 종합적인 디지털 헬스 생태계를 형성하고 있습니다. 지불자와 의료 서비스 제공자에게 SaMD는 조기 발견, 위험 계층화 및 개입을 위한 도구를 제공하여 입원율을 낮추고 비용 효율성을 개선할 수 있도록 지원합니다.

FDA의 디지털 헬스 소프트웨어 사전 인증 프로그램, EU의 의료기기 규제(MDR), 일본의 의약품의료기기종합기구(PMDA)는 SaMD에 맞는 합리적인 경로를 도입하고 있습니다. 경로를 도입하고 있습니다. 이러한 프레임워크는 시판 후 조사, 사용자 중심 설계, 실제 성능 검증에 중점을 두고 있으며, SaMD는 하드웨어와 독립적으로 작동하기 때문에 지역 간 빠르게 확장할 수 있고, 자원이 제한된 의료 환경에서 특히 효과적입니다. SaMD는 가치 기반 의료 모델이 전 세계적으로 확대되는 가운데, SaMD는 능동적이고 개인화된 의료 서비스의 핵심이 될 준비가 되어 있습니다.

AI, 머신러닝, 실제 데이터는 어떻게 SaMD의 진화를 촉진하는가?

인공지능과 머신러닝은 SaMD 혁신의 핵심입니다. 이러한 기술을 통해 소프트웨어는 방대한 데이터세트를 분석하고, 패턴을 식별하고, 높은 정확도로 예측 평가를 할 수 있습니다. 영상의학 분야에서 AI를 탑재한 SaMD는 영상 스캔에서 종양이나 골절과 같은 이상 징후를 인간 전문의와 동등하거나 그 이상의 정확도로 감지할 수 있습니다. 심장학에서는 ML 알고리즘이 ECG 신호에서 부정맥과 심부전 지표를 평가합니다. 행동 건강 분야에서 SaMD 솔루션은 대화 패턴, 표정, 디지털 대화 데이터를 통해 불안과 우울증의 초기 징후를 감지하도록 훈련되어 있습니다. 이러한 기능은 진단의 정확도를 높일 뿐만 아니라, 보다 빠르고 개인화된 개입을 가능하게 합니다.

실제 데이터(RWD)와 실제 증거(RWE)는 SaMD의 가치 제안을 더욱 발전시키고 있습니다. 소프트웨어 플랫폼이 웨어러블, 전자 의료 기록, 환자 보고 결과의 데이터를 통합함에 따라 지속적인 학습과 실시간 위험 평가를 위한 강력한 도구가 될 것입니다. 개발자들은 클라우드 인프라와 협업 학습 모델을 활용하여 데이터의 프라이버시를 보장하면서 다양한 집단에서 알고리즘의 성능을 향상시키고 있습니다. 이러한 피드백 루프를 통해 규제 당국은 적응형 알고리즘(새로운 증거에 따라 승인 후 진화하는 SaMD 제품)을 승인할 수 있습니다. 사이버 보안, HIPAA 컴플라이언스, 사용자 인증 시스템을 통합하여 이러한 솔루션의 안전성과 신뢰성을 보장합니다.

SaMD(Software as a Medical Device)의 급성장 요인은?

SaMD(Software as a Medical Device) 시장의 성장은 디지털 헬스 산업 전반의 몇 가지 시너지 효과에 의해 이루어지고 있습니다. 특히 만성질환 및 생활습관병에 대한 원격진료 및 자가 관리 도구에 대한 수요 증가가 그 중 하나입니다. 환자들이 자신의 건강을 모니터링하기 위해 모바일 앱과 커넥티드 플랫폼에 대한 의존도가 높아지는 가운데, SaMD는 임상 현장과 재택 진료의 간극을 메워주고 있습니다. 또한, 신흥 시장에서의 스마트폰과 클라우드 인프라의 보급으로 SaMD에 대한 접근이 민주화되어, 의료 서비스를 제대로 받지 못하는 사람들도 AI 기반 헬스케어 솔루션의 혜택을 누릴 수 있게 되었습니다.

제약 및 의료 기술 기업들은 SaMD를 제품의 치료 효과를 확장하고 시판 후 지식을 수집하는 수단으로 인식하고 시장 출시 전략에 빠르게 도입하고 있습니다. 한편, 병원과 지불자는 SaMD를 선별진료 자동화, 환자 참여, 조기 발견, 응급실 업무 부담 경감, 진료 연계 개선에 활용하고 있습니다. 마지막으로, SaMD 스타트업에 대한 벤처 캐피털과 사모펀드의 투자는 사상 최고 수준으로, 시장의 신뢰가 높다는 것을 보여줍니다. 의료 시스템이 개인화, 데이터 중심, 예방적 치료 모델로 진화하는 가운데, SaMD는 전 세계 의료 서비스 제공에 있어 임상적 도구이자 전략적 차별화 요소로 작용할 수 있는 위치에 있습니다.

부문

전개(클라우드, 온프레미스), 용도(스크리닝 및 진단, 모니터링 및 알림, 만성질환 관리, 디지털 치료, 기타 용도), 최종 용도(병원 및 클리닉, 재택의료, 기타 최종 용도)

조사 대상 기업 사례(총 43개사)

  • AliveCor
  • Apple Inc.
  • Arterys Inc.
  • Biofourmis
  • Brainlab
  • Cerner Corporation
  • Digital Diagnostics Inc.
  • GE Healthcare
  • Google Health
  • Health Catalyst
  • IBM Watson Health
  • iSchemaView Inc.
  • Medtronic plc
  • MindMaze
  • Microsoft Health
  • Philips Healthcare
  • Qlarity Imaging LLC
  • Samsung Health
  • Siemens Healthineers
  • Viz.ai

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 매출원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사하고 있습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월 : 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월 : 최종 관세 재설정

고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석:

미국 <> 중국 <> 멕시코 <> 캐나다 <> EU <> 일본 <> 인도 <> 기타 176개국

업계 최고의 이코노미스트 : Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트 그룹을 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정을 적용하고 있습니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.06.13

Global Software as a Medical Device Market to Reach US$53.7 Million by 2030

The global market for Software as a Medical Device estimated at US$22.2 Million in the year 2024, is expected to reach US$53.7 Million by 2030, growing at a CAGR of 15.9% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 14.1% CAGR and reach US$32.0 Million by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 18.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.0 Million While China is Forecast to Grow at 20.7% CAGR

The Software as a Medical Device market in the U.S. is estimated at US$6.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.6 Million by the year 2030 trailing a CAGR of 20.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.9% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.

Global Software as a Medical Device Market - Key Trends & Drivers Summarized

Can Code Alone Cure? Why Software as a Medical Device Is Rewriting Healthcare Norms

Software as a Medical Device (SaMD) is revolutionizing healthcare by allowing software programs-independent of any hardware-to perform functions such as diagnosis, treatment recommendation, or disease monitoring. Unlike traditional software embedded within devices, SaMD operates autonomously on mobile devices, cloud platforms, or desktop applications, enabling remote patient management and data-driven clinical decision-making. From detecting cardiac arrhythmias via smartphone ECG algorithms to optimizing insulin dosing through predictive diabetes software, SaMD is transforming how healthcare is delivered, particularly in chronic disease management, mental health, radiology, and digital therapeutics.

What makes SaMD particularly disruptive is its ability to deliver clinical functionality at scale without the need for physical manufacturing. This agility allows rapid updates, iterative improvements, and real-time data analysis-all essential in managing complex conditions like oncology, neurology, and rare diseases. Additionally, the COVID-19 pandemic accelerated the validation of SaMD tools for remote diagnostics and digital triage, paving the way for regulatory agencies like the FDA and EMA to establish fast-track pathways for their approval. The demand for personalized, non-invasive, and continuous monitoring solutions has never been higher, positioning SaMD as a linchpin in the evolving continuum of care.

Why Are Stakeholders from Pharma to Payers Rallying Behind SaMD?

The convergence of cloud computing, artificial intelligence, and mobile technologies has created a fertile environment for SaMD deployment across both clinical and consumer settings. Pharmaceutical companies are increasingly integrating SaMD into their drug development and post-marketing surveillance strategies, using digital biomarkers and real-world data to enhance therapeutic efficacy and monitor patient adherence. These software solutions are also being bundled with companion diagnostics, connected drug delivery devices, and wearable sensors to form comprehensive digital health ecosystems. For payers and providers, SaMD offers tools for early detection, risk stratification, and intervention that can reduce hospitalization rates and improve cost efficiency.

Regulatory bodies have responded by establishing frameworks that ensure patient safety without stifling innovation. The FDA’s Digital Health Software Precertification Program, the EU Medical Device Regulation (MDR), and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) have introduced streamlined pathways tailored for SaMD. These frameworks emphasize post-market surveillance, user-centric design, and real-world performance validation. SaMD’s ability to operate independently of hardware allows it to scale rapidly across geographies, making it especially effective in resource-constrained healthcare settings. As value-based care models expand globally, SaMD is poised to become a core enabler of proactive, personalized healthcare.

How Are AI, Machine Learning, and Real-World Data Powering SaMD Evolution?

Artificial intelligence and machine learning are at the heart of SaMD innovation. These technologies allow software to analyze vast datasets, identify patterns, and make predictive assessments with high precision. In radiology, AI-powered SaMD can detect abnormalities such as tumors or fractures from imaging scans with accuracy comparable to or exceeding human specialists. In cardiology, ML algorithms assess ECG signals for arrhythmias or heart failure indicators. In behavioral health, SaMD solutions are being trained to detect early signs of anxiety or depression through speech patterns, facial expressions, and digital interaction data. These capabilities are not just enhancing diagnostic accuracy but enabling earlier and more personalized interventions.

Real-world data (RWD) and real-world evidence (RWE) are further propelling the value proposition of SaMD. As software platforms integrate data from wearables, electronic health records, and patient-reported outcomes, they become powerful tools for continuous learning and real-time risk assessment. Developers are leveraging cloud infrastructure and federated learning models to ensure data privacy while improving algorithmic performance across diverse populations. This feedback loop is enabling regulatory agencies to approve adaptive algorithms-SaMD products that evolve post-approval based on new evidence. The integration of cybersecurity, HIPAA compliance, and user authentication systems ensures that these solutions remain secure and trustworthy.

What’s Fueling the Exponential Rise of Software as a Medical Device?

The growth in the software as a medical device market is driven by several synergistic forces across the digital health landscape. Chief among them is the escalating demand for remote care and self-management tools, especially in chronic and lifestyle-driven diseases. With patients increasingly relying on mobile apps and connected platforms to monitor their health, SaMD is bridging the gap between clinical settings and home-based care. Moreover, the proliferation of smartphones and cloud infrastructure in emerging markets is democratizing access to SaMD, allowing underserved populations to benefit from AI-driven healthcare solutions.

Pharmaceutical and medtech companies are rapidly incorporating SaMD into their go-to-market strategies, viewing it as a means to extend the therapeutic impact of their products and gather post-market insights. Meanwhile, hospitals and payers are leveraging SaMD for triage automation, patient engagement, and early detection to reduce the burden on emergency departments and improve care coordination. Finally, venture capital and private equity investment in SaMD startups is at an all-time high, signaling strong market confidence. As healthcare systems evolve toward personalized, data-centric, and preventive care models, SaMD is positioned to serve as both a clinical tool and a strategic differentiator in global healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Software as a Medical Device market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Deployment (Cloud, On-Premise); Application (Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics, Other Applications); End-Use (Hospitals & Clinics, Home Care Settings, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • AliveCor
  • Apple Inc.
  • Arterys Inc.
  • Biofourmis
  • Brainlab
  • Cerner Corporation
  • Digital Diagnostics Inc.
  • GE Healthcare
  • Google Health
  • Health Catalyst
  • IBM Watson Health
  • iSchemaView Inc.
  • Medtronic plc
  • MindMaze
  • Microsoft Health
  • Philips Healthcare
  • Qlarity Imaging LLC
  • Samsung Health
  • Siemens Healthineers
  • Viz.ai

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Software as a Medical Device - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Regulatory Recognition of Software-Based Therapeutics Drives Market Legitimacy and Growth
    • Accelerated Adoption of Digital Health and Remote Monitoring Expands Application Scope
    • Increased Investment in AI-Powered Diagnostics and Predictive Algorithms Fuels Innovation
    • Widespread Use in Chronic Disease Management Strengthens Clinical Integration
    • Mobile and Wearable Integration Enhances Real-Time Patient Engagement
    • Regulatory Frameworks Like FDA and EU MDR Enable Clarity and Global Expansion
    • Use in Personalized Medicine and Data-Driven Treatment Planning Expands Precision Health Opportunities
    • Mental Health and Behavioral Therapy Applications Create Rapid Adoption Pathways
    • Reimbursement Inclusion in Select Markets Drives Payor-Supported Growth
    • Cybersecurity and Data Integrity Challenges Highlight the Need for Robust Infrastructure
    • Partnerships Between Tech Startups and Medical Device Firms Accelerate Product Development
    • Rise in Clinical Validation and Real-World Evidence Collection Strengthens Market Trust
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Software as a Medical Device Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Software as a Medical Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Screening & Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Screening & Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Screening & Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Monitoring & Alerting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Monitoring & Alerting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Monitoring & Alerting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Chronic Disease Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Chronic Disease Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Chronic Disease Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Software as a Medical Device by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Software as a Medical Device by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Software as a Medical Device by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Software as a Medical Device by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Software as a Medical Device by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Software as a Medical Device Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Software as a Medical Device by Deployment - Cloud and On-Premise - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Software as a Medical Device by Deployment - Cloud and On-Premise Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Software as a Medical Device by Deployment - Percentage Breakdown of Value Sales for Cloud and On-Premise for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Software as a Medical Device by End-Use - Other End-Uses, Hospitals & Clinics and Home Care Settings Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Software as a Medical Device by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Home Care Settings for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Software as a Medical Device by Application - Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Software as a Medical Device by Application - Percentage Breakdown of Value Sales for Screening & Diagnosis, Monitoring & Alerting, Chronic Disease Management, Digital Therapeutics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제